D
Donald E. Low
Researcher at University of Toronto
Publications - 362
Citations - 25624
Donald E. Low is an academic researcher from University of Toronto. The author has contributed to research in topics: Population & Streptococcus pneumoniae. The author has an hindex of 88, co-authored 359 publications receiving 24384 citations. Previous affiliations of Donald E. Low include Trillium Health Centre & New York City Department of Health and Mental Hygiene.
Papers
More filters
Journal ArticleDOI
Vancomycin-resistant enterococci.
Allison McGeer,Donald E. Low +1 more
TL;DR: Control of the transmission of VRE, although successful in preventing infections, is neither simple nor inexpensive, and VRE has become endemic in many hospitals, and it seems likely that such control programs represent significant cost savings for those hospitals willing to undertake them.
Journal ArticleDOI
The Treatment of Severe Group A Streptococcal Infections.
TL;DR: Novel therapeutic strategies include agents that can inhibit these superantigenic activities, and one promising candidate is intravenous polyspecific immunoglobulin that contains neutralizing antibodies against a wide spectrum of streptococcal superantigens.
Journal ArticleDOI
Assessing the Impact of Intravenous Immunoglobulin in the Management of Streptococcal Toxic Shock Syndrome: A Noble but Difficult Quest
TL;DR: The annual incidence of invasive group A streptococcal disease in the developed world has been stable for at least 2 decades at 2.0–4.0 cases per 100,000 persons per year and 2 prior publications have attempted to assess the efficacy of intrave-
Journal ArticleDOI
Non-Invasive Cytology Brush PCR for the Diagnosis and Causative Species Identification of American Cutaneous Leishmaniasis in Peru
Braulio M. Valencia,Nicolas Veland,Milena Alba,Vanessa Adaui,Jorge Arevalo,Donald E. Low,Alejandro Llanos-Cuentas,Andrea K. Boggild,Andrea K. Boggild +8 more
TL;DR: Cytology brush PCR constitutes a sensitive and specific alternative to traditional diagnostic assays performed on invasive specimens such as lesion scrapings and performs comparatively to non-invasive FPLI PCR.
Journal ArticleDOI
Pandemic planning: non-pharmaceutical interventions.
TL;DR: Concerns about the emergence of an influenza pandemic continue as the number of avian and human infections with the H5N1 virus mount, and the use of non‐pharmaceutical public health interventions to inhibit human‐to‐human transmission is focused on.